Literature DB >> 29970455

Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.

Chun Jye Lim1, Yun Hua Lee1, Salvatore Albani1, Valerie Chew1, Lu Pan1, Liyun Lai1, Camillus Chua1, Martin Wasser1, Tony Kiat Hon Lim2,3, Joe Yeong2,4, Han Chong Toh3,5, Ser Yee Lee3,5,6, Chung Yip Chan3,5,6, Brian Kp Goh3,5,6, Alexander Chung3,5,6, Mathias Heikenwälder7, Irene Ol Ng8, Pierce Chow3,5,6.   

Abstract

BACKGROUND AND AIMS: Chronic inflammation induced by chronic hepatitis B virus (HBV) infection increases the risk of hepatocellular carcinoma (HCC). However, little is known about the immune landscape of HBV-related HCC and its influence on the design of effective cancer immunotherapeutics.
METHODS: We interrogated the immune microenvironments of HBV-related HCC and non-viral-related HCC using immunohistochemistry and cytometry by time-of-flight (CyTOF). On identifying unique immune subsets enriched in HBV-related HCC, we further interrogated their phenotypes and functions using next-generation sequencing (NGS) and in vitro T-cell proliferation assays.
RESULTS: In-depth interrogation of the immune landscapes showed that regulatory T cells (TREG) and CD8+ resident memory T cells (TRM) were enriched in HBV-related HCC, whereas Tim-3+CD8+ T cells and CD244+ natural killer cells were enriched in non-viral-related HCC. NGS of isolated TREG and TRM from HBV-related HCC and non-viral-related HCC identified distinct functional signatures associated with T-cell receptor signalling, T-cell costimulation, antigen presentation and programmed cell death protein 1 (PD-1) signalling. TREG and TRM from HBV-related HCC expressed more PD-1 and were functionally more suppressive and exhausted than those from non-virus-related HCC. Furthermore, immunosuppression by PD-1+ TREG could be reversed with anti-PD-1 blockade. Using multiplexed tissue immunofluorescence, we further demonstrated that TREG and TRM contributed to overall patient survival: TREG were associated with a poor prognosis and TRM were associated with a good prognosis in HCC.
CONCLUSION: We have shown that the HBV-related HCC microenvironment is more immunosuppressive and exhausted than the non-viral-related HCC microenvironment. Such in-depth understanding has important implications in disease management and appropriate application of immunotherapeutics. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer immunobiology; hepatitis B; hepatocellular carcinoma; immunoregulation; immunotherapy

Mesh:

Year:  2018        PMID: 29970455     DOI: 10.1136/gutjnl-2018-316510

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  87 in total

1.  Immunotherapy: New Options in Gastrointestinal Cancers?

Authors:  Andrea Tannapfel; Anke Reinacher-Schick; Ulrich Hacker; Sylvie Lorenzen; Markus Möhler; Arndt Vogel
Journal:  Visc Med       Date:  2019-02-14

Review 2.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

Review 3.  Tissue-resident memory T cells in the skin.

Authors:  Samar Khalil; Tara Bardawil; Mazen Kurban; Ossama Abbas
Journal:  Inflamm Res       Date:  2020-01-27       Impact factor: 4.575

Review 4.  Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors.

Authors:  Akshitkumar M Mistry; Allison R Greenplate; Rebecca A Ihrie; Jonathan M Irish
Journal:  FEBS J       Date:  2019-01-07       Impact factor: 5.542

Review 5.  Liver-resident memory T cells: life in lockdown.

Authors:  Laura J Pallett; Mala K Maini
Journal:  Semin Immunopathol       Date:  2022-04-28       Impact factor: 9.623

6.  Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE.

Authors:  Hongyu Wang; Guixiong Zhang; Wenzhe Fan; Yanqin Wu; Jiang Zhang; Miao Xue; Yue Zhao; Wang Yao; Jiaping Li
Journal:  Cancer Manag Res       Date:  2022-02-05       Impact factor: 3.989

7.  Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.

Authors:  Yuhao Wang; Jie Yang; Qijie Zhang; Jiadong Xia; Zengjun Wang
Journal:  Transl Androl Urol       Date:  2019-12

8.  HBsAg-specific CD8+ T cells as an indispensable trigger to induce murine hepatocellular carcinoma.

Authors:  Xiaolei Hao; Yongyan Chen; Lu Bai; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2019-11-25       Impact factor: 11.530

9.  An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma.

Authors:  Kunlun Chen; Pengfei Zhu; Yuan Liao; Lei Yan; Ruo Feng; Wenlong Zhai
Journal:  Onco Targets Ther       Date:  2021-03-02       Impact factor: 4.147

Review 10.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.